Vancouver, British Columbia – The Newswire – September 2, 2020 – Naturally Splendid Enterprises Ltd. (“Naturally Splendid”, “NSE” or “the Company”) (FRANKFURT:50N) (TSXV:NSP)(OTC:NSPDF) is pleased to announce that it has entered into a Definitive Agreement with Vancouver-based Biologic Pharmamedical Research (“Biologic”) to form a joint venture for the purpose offurther developing and pursuing phase 2 clinical studies for a potential COVID-19 treatment, utilizing one of Biologic’s patented technologies as a candidate.